Imagen de Portada

Research Communication: Prevalence of Asymptomatic Premalignant Oesophageal Lesions in Patients With Fanconi Anaemia

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Joshua A. Sloan, Nicha Wongjarupong, Vikram Christian, Nabeel Azeem, Kevin O. Turner, C. Prakash Gyawali, Margaret L. MacMillan, John E. Wagner
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Alimentary Pharmacology & Therapeutics
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Editorial: The Milan Score as Supportive Evidence of Gastro‐Oesophageal Reflux Disease. Authors' Reply
por: Stefano Siboni, et al.
Publicado: (2026)

Integrated Analysis of Vonoprazan Safety for Symptomatic Gastro‐Oesophageal Reflux Disease or Erosive Oesophagitis
por: Colin W. Howden, et al.
Publicado: (2024)

Letter Regarding ‘Combined Lyon and Milan Scores Predict Gerd Management Outcome Better Than Either Score Alone or Their Individual Components’. Authors' Reply
por: Stefano Siboni, et al.
Publicado: (2025)

Editorial: Do we Need to Adapt GERD Metrics Based on the Population Being Evaluated? Authors' Reply
por: Walter W. Chan, et al.
Publicado: (2026)

Letter: From Regional Diagnostic Thresholds to Phenotype‐Guided Management in Asian Reflux Disease. Authors' Reply
por: Walter W. Chan, et al.
Publicado: (2026)

Clinical Trial: Safety and Efficacy of a Novel Oesophageal Delivery System for Topical Corticosteroids Versus Placebo in the Treatment of Eosinophilic Oesophagitis
por: Alfredo J. Lucendo, et al.
Publicado: (2024)

Systematic Review: Variability in Definitions of Fibrostenosis in Eosinophilic Oesophagitis
por: Claire A. Beveridge, et al.
Publicado: (2025)

Letter: Helicobacter pylori and Eosinophilic Oesophagitis—Lost in Definition?
por: Fernanda Cristofori, et al.
Publicado: (2025)

Review article: Oesophageal disorders in chronic liver disease
por: Francisco Idalsoaga, et al.
Publicado: (2024)

Review article: Seeing Is Believing–The Eosinophilic Oesophagitis Endoscopic Reference Score Can Serve as a Valuable Clinical Trial Endpoint in Eosinophilic Oesophagitis
por: Ikuo Hirano, et al.
Publicado: (2025)

Editorial: The Milan Score as Supportive Evidence of Gastro‐Oesophageal Reflux Disease
por: Javier Chahuán, et al.
Publicado: (2026)

Systematic Review: Use of Artificial Intelligence and Unmet Needs in Eosinophilic Oesophagitis
por: Ester Castagnaro, et al.
Publicado: (2025)

Letter: Helicobacter pylori and Eosinophilic Oesophagitis—Lost in Definition? Authors' Reply
por: Irene Spinelli, et al.
Publicado: (2025)

Letter: Peripheral Eosinophilia Does Not Correlate With Endoscopic and Histological Activity in Paediatric Eosinophilic Oesophagitis
por: Saverio Pochesci, et al.
Publicado: (2026)

Letter: Meta‐Analysis Critique: Refining the Association Between Helicobacter pylori and Eosinophilic Oesophagitis
por: Haleema Rahman
Publicado: (2025)

Blood Eosinophils Are Accurate Biomarkers for the Management of Eosinophilic Oesophagitis: Prospective, Multi‐Centre Study
por: Pierfrancesco Visaggi, et al.
Publicado: (2026)

Letter: Peripheral Eosinophilia Does Not Correlate With Endoscopic and Histological Activity in Paediatric Eosinophilic Oesophagitis. Authors' Reply
por: Pierfrancesco Visaggi, et al.
Publicado: (2026)

Letter: Disappearing Microbe, Emerging Disease? Nuancing the Protective Effects of Helicobacter pylori Against Eosinophilic Oesophagitis
por: Enzo Emanuele, et al.
Publicado: (2025)

Research Communication: Real‐World Effectiveness of Budesonide Orodispersible Tablets for Eosinophilic Oesophagitis: The Importance of Patience and Education
por: Sarah Taylor, et al.
Publicado: (2025)

Letter: Disappearing Microbe, Emerging Disease? Nuancing the Protective Effects of Helicobacter pylori Against Eosinophilic Oesophagitis. Authors' Reply
por: Irene Spinelli, et al.
Publicado: (2025)

Clinical Trial: Dose‐Finding Study of Linaprazan Glurate, A Novel Potassium‐Competitive Acid Blocker, Versus Lansoprazole for the Treatment of Erosive Oesophagitis
por: Prateek Sharma, et al.
Publicado: (2025)

Meta‐Analysis: Prevalence of Eating Disorders in Inflammatory Bowel Disease
por: Quinn Goddard, et al.
Publicado: (2025)

Meta‐Analysis: Prevalence and Incidence of Gastroparesis Following Lung or Heart Transplantation
por: Mohamed H. Eldesouki, et al.
Publicado: (2026)

Cholate Shunt, Oral Cholate Challenge and Endoscopic Lesions of Portal Hypertension: The SHUNT‐V Study
por: Mitchell Shiffman, et al.
Publicado: (2024)

A Prospective Study on the Prevalence of MASLD in Patients With Type 2 Diabetes and Hyperferritinaemia
por: Maral Amangurbanova, et al.
Publicado: (2024)

Prevalence and prognostic value of zinc and selenium deficiency in advanced chronic liver disease
por: Nina Dominik, et al.
Publicado: (2024)

Letter: Meta‐Analysis: Prevalence of Frailty and Associated Adverse Events in Inflammatory Bowel Disease
por: Cong Dai, et al.
Publicado: (2024)

Prevalence of Low FIB‐4 in MASLD‐Related Hepatocellular Carcinoma: A Multicentre Study
por: Darren Jun Hao Tan, et al.
Publicado: (2024)

Letter: A Prospective Study on the Prevalence of MASLD in Patients With Type 2 Diabetes and Hyperferritinaemia
por: Xiaojuan Liu, et al.
Publicado: (2025)

Functional Dyspepsia and Its Subgroups: Prevalence and Impact in the Rome IV Global Epidemiology Study
por: J. Tack, et al.
Publicado: (2025)

Prevalence and Predictors of Symptoms of Anxiety or Depression at Diagnosis in Patients With Inflammatory Bowel Disease: An Inception Cohort
por: Christy Riggott, et al.
Publicado: (2025)

Meta‐Analysis: Global Prevalence and Mortality of Cirrhosis in Metabolic Dysfunction‐Associated Steatotic Liver Disease
por: Soroor Owrangi, et al.
Publicado: (2024)

Prevalence of at‐risk MASH, MetALD and alcohol‐associated steatotic liver disease in the general population
por: Carolin V. Schneider, et al.
Publicado: (2024)

Prevalence and Predictors of Suspected Metabolic Dysfunction‐Associated Steatotic Liver Disease in Adolescents in the United States
por: Sheila L. Noon, et al.
Publicado: (2025)

Editorial: Emulsifiers and thickeners in our food—Do they alter gut permeability?
por: Joshua Reid, et al.
Publicado: (2024)

Prevalence of Opioid Use and Associated Healthcare Outcomes in Rome IV Irritable Bowel Syndrome in the United Kingdom
por: Mohsin F. Butt, et al.
Publicado: (2025)

Letter: Meta‐Analysis: Prevalence of Frailty and Associated Adverse Events in Inflammatory Bowel Disease—Authors' Reply
por: Isabel Carbery, et al.
Publicado: (2024)

Letter: Increased Prevalence of Visceral Obesity in Nonresponder Patients With Primary Biliary Cholangitis Based on Computed Tomography
por: Bo Li, et al.
Publicado: (2024)

The Prevalence and Risk Factors for at‐Risk MASH and Advanced Liver Fibrosis in People With Metabolic Risk Factors in Primary Care
por: Leon A. Adams, et al.
Publicado: (2026)

Letter: Increased Prevalence of Visceral Obesity in Nonresponder Patients With Primary Biliary Cholangitis Based on Computed Tomography—Authors' Reply
por: Conrado Fernandez‐Rodriguez, et al.
Publicado: (2024)